ERIC DOBMEIER Insider Trading $SGEN Seagen Inc.
Get free email notifications about insider trading for ERIC DOBMEIER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC DOBMEIER. ERIC DOBMEIER is Chief Business Officer in SEATTLE GENETICS INC /WA ($SGEN) and Chief Operating Officer in SEATTLE GENETICS INC /WA ($SGEN) and Sr. VP, Corporate Development in SEATTLE GENETICS INC /WA ($SGEN) and V. P., Corporate Affairs in SEATTLE GENETICS INC /WA ($SGEN) and Vice President, in SEATTLE GENETICS INC /WA ($SGEN) and Director in STEMLINE THERAPEUTICS INC ($STML) and President, CEO in ADURO BIOTECH, INC. ($ADRO) and Director in Adaptive Biotechnologies Corp ($ADPT) and Director in Versartis, Inc. ($VSAR) and Director in Atara Biotherapeutics, Inc. ($ATRA).
ERIC DOBMEIER in Seagen Inc.
Trading Symbol: SGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC DOBMEIER: Chief Operating Officer, Chief Business Officer, Sr. VP, Corporate Development, V. P., Corporate Affairs, Vice President,
Holdings: 121,153 shares
Current Value: $7,364,891
Latest Transaction: Dec 06 2017
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ERIC DOBMEIER in Seagen Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, ARAV, ATRA, ADRO, SGEN, STML
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 06 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 26.10 | 3,729 | 97,327 | 24,700 | |
Dec 06 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 41.04 | 2,436 | 99,973 | 0 | |
Dec 06 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 41.04 | 2,436 | 99,973 | 119,860 | 117.4 K to 119.9 K (+2.07 %) |
Dec 06 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 58.75 | 3,729 | 219,092 | 117,424 | 121.2 K to 117.4 K (-3.08 %) |
Dec 06 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 26.10 | 3,729 | 97,327 | 121,153 | 117.4 K to 121.2 K (+3.18 %) |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 26.10 | 10,000 | 261,000 | 28,429 | |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 26.10 | 6,911 | 180,377 | 38,429 | |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 8,489 | 131,240 | 0 | |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 9,600 | 148,416 | 8,489 | |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 59.13 | 10,000 | 591,250 | 117,424 | 127.4 K to 117.4 K (-7.85 %) |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 26.10 | 10,000 | 261,000 | 127,424 | 117.4 K to 127.4 K (+8.52 %) |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 57.95 | 8,489 | 491,938 | 117,424 | 125.9 K to 117.4 K (-6.74 %) |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 8,489 | 131,240 | 125,913 | 117.4 K to 125.9 K (+7.23 %) |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 57.98 | 6,911 | 400,700 | 117,424 | 124.3 K to 117.4 K (-5.56 %) |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 26.10 | 6,911 | 180,377 | 124,335 | 117.4 K to 124.3 K (+5.89 %) |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 57.80 | 9,600 | 554,837 | 117,424 | 127 K to 117.4 K (-7.56 %) |
Nov 17 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 9,600 | 148,416 | 127,024 | 117.4 K to 127 K (+8.18 %) |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 25,000 | 386,500 | 18,089 | |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 52.24 | 25,000 | 1,305,893 | 117,424 | 142.4 K to 117.4 K (-17.55 %) |
Sep 05 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 25,000 | 386,500 | 142,424 | 117.4 K to 142.4 K (+21.29 %) |
Aug 30 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 47.89 | 5,343 | 255,900 | 117,424 | 122.8 K to 117.4 K (-4.35 %) |
Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 46.37 | 85,344 | 3,957,401 | 85,344 | |
Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 46.37 | 2,156 | 99,974 | 2,156 | |
Aug 18 2017 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 35,000 | 0 | 122,767 | 87.8 K to 122.8 K (+39.88 %) |
Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 9,700 | 199,044 | 0 | |
Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 2,800 | 57,456 | 9,700 | |
Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 65.90 | 9,700 | 639,234 | 87,767 | 97.5 K to 87.8 K (-9.95 %) |
Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 9,700 | 199,044 | 97,467 | 87.8 K to 97.5 K (+11.05 %) |
Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 66.00 | 2,800 | 184,808 | 87,767 | 90.6 K to 87.8 K (-3.09 %) |
Dec 12 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 2,800 | 57,456 | 90,567 | 87.8 K to 90.6 K (+3.19 %) |
Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.00 | 300 | 3,600 | 0 | |
Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.00 | 22,618 | 271,416 | 300 | |
Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 54.41 | 300 | 16,324 | 87,767 | 88.1 K to 87.8 K (-0.34 %) |
Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.00 | 300 | 3,600 | 88,067 | 87.8 K to 88.1 K (+0.34 %) |
Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 54.03 | 22,618 | 1,222,146 | 87,767 | 110.4 K to 87.8 K (-20.49 %) |
Sep 15 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.00 | 22,618 | 271,416 | 110,385 | 87.8 K to 110.4 K (+25.77 %) |
Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 45.30 | 70,293 | 3,184,273 | 70,293 | |
Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 45.30 | 2,207 | 99,977 | 2,207 | |
Aug 30 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 29,000 | 0 | 87,767 | 58.8 K to 87.8 K (+49.35 %) |
Aug 24 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 26.10 | 3,831 | 99,989 | 0 | |
Aug 24 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 48.00 | 12,589 | 604,272 | 58,767 | 71.4 K to 58.8 K (-17.64 %) |
Aug 24 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 26.10 | 3,831 | 99,989 | 71,356 | 67.5 K to 71.4 K (+5.67 %) |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 46.59 | 5,411 | 252,102 | 67,525 | 72.9 K to 67.5 K (-7.42 %) |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 39.15 | 44,946 | 1,759,636 | 44,946 | |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 4,688 | 96,198 | 0 | |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 245 | 3,788 | 0 | |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 19,000 | 0 | 98,340 | 79.3 K to 98.3 K (+23.95 %) |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 245 | 3,788 | 79,340 | 79.1 K to 79.3 K (+0.31 %) |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 4,688 | 96,198 | 79,095 | 74.4 K to 79.1 K (+6.30 %) |
Aug 22 2016 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 42.02 | 8,548 | 359,226 | 74,407 | 83 K to 74.4 K (-10.30 %) |
Nov 06 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 42.50 | 17,452 | 741,710 | 80,888 | 98.3 K to 80.9 K (-17.75 %) |
Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 39.15 | 44,946 | 1,759,636 | 44,946 | |
Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 39.15 | 2,554 | 99,989 | 2,554 | |
Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 4,688 | 96,198 | 0 | |
Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 245 | 3,788 | 0 | |
Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 19,000 | 0 | 98,340 | 79.3 K to 98.3 K (+23.95 %) |
Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 245 | 3,788 | 79,340 | 79.1 K to 79.3 K (+0.31 %) |
Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 4,688 | 96,198 | 79,095 | 74.4 K to 79.1 K (+6.30 %) |
Aug 25 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 42.02 | 8,548 | 359,226 | 74,407 | 83 K to 74.4 K (-10.30 %) |
May 08 2015 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 40.38 | 17,074 | 689,380 | 82,777 | 99.9 K to 82.8 K (-17.10 %) |
Aug 28 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.00 | 8,333 | 99,996 | 0 | |
Aug 28 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.00 | 8,333 | 99,996 | 99,765 | 91.4 K to 99.8 K (+9.11 %) |
Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 44.09 | 42,732 | 1,884,054 | 42,732 | |
Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 44.09 | 2,268 | 99,996 | 2,268 | |
Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 18,000 | 0 | 91,432 | 73.4 K to 91.4 K (+24.51 %) |
Aug 27 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 43.55 | 4,818 | 209,819 | 73,432 | 78.3 K to 73.4 K (-6.16 %) |
Jan 23 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 48.02 | 14,959 | 718,271 | 77,833 | 92.8 K to 77.8 K (-16.12 %) |
Jan 23 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 47.90 | 19,616 | 939,518 | 92,792 | 112.4 K to 92.8 K (-17.45 %) |
Jan 23 2014 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 47.87 | 21,435 | 1,026,168 | 112,408 | 133.8 K to 112.4 K (-16.02 %) |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 26.10 | 15,829 | 413,137 | 45,340 | |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 20.52 | 20,312 | 416,802 | 12,500 | |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 3,859 | 59,660 | 43,089 | |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 46.45 | 2,000 | 92,900 | 133,843 | 135.8 K to 133.8 K (-1.47 %) |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 46.40 | 15,829 | 734,489 | 135,843 | 151.7 K to 135.8 K (-10.44 %) |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 26.10 | 15,829 | 413,137 | 151,672 | 135.8 K to 151.7 K (+11.65 %) |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 46.40 | 3,859 | 179,063 | 135,843 | 139.7 K to 135.8 K (-2.76 %) |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 3,859 | 59,660 | 139,702 | 135.8 K to 139.7 K (+2.84 %) |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 46.40 | 20,312 | 942,507 | 135,843 | 156.2 K to 135.8 K (-13.01 %) |
Sep 11 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 20.52 | 20,312 | 416,802 | 156,155 | 135.8 K to 156.2 K (+14.95 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 15,000 | 231,900 | 46,948 | |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 15.46 | 24,474 | 378,368 | 61,948 | |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.16 | 6,333 | 77,009 | 0 | |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.00 | 29,193 | 350,316 | 22,918 | |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.16 | 8,223 | 99,992 | 0 | |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 44.00 | 15,000 | 660,000 | 135,843 | 150.8 K to 135.8 K (-9.94 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 15,000 | 231,900 | 150,843 | 135.8 K to 150.8 K (+11.04 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 42.29 | 24,474 | 1,035,113 | 135,843 | 160.3 K to 135.8 K (-15.27 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 15.46 | 24,474 | 378,368 | 160,317 | 135.8 K to 160.3 K (+18.02 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 42.29 | 29,193 | 1,234,700 | 135,843 | 165 K to 135.8 K (-17.69 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.00 | 29,193 | 350,316 | 165,036 | 135.8 K to 165 K (+21.49 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 42.29 | 6,333 | 267,850 | 135,843 | 142.2 K to 135.8 K (-4.45 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.16 | 6,333 | 77,009 | 142,176 | 135.8 K to 142.2 K (+4.66 %) |
Sep 05 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.16 | 8,223 | 99,992 | 135,843 | 127.6 K to 135.8 K (+6.44 %) |
Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 41.04 | 42,564 | 1,746,827 | 42,564 | |
Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 41.04 | 2,436 | 99,973 | 2,436 | |
Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 18,000 | 0 | 127,620 | 109.6 K to 127.6 K (+16.42 %) |
Aug 21 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 40.91 | 3,328 | 136,148 | 109,620 | 112.9 K to 109.6 K (-2.95 %) |
Mar 12 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.16 | 35,444 | 430,999 | 6,333 | |
Mar 12 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.00 | 14,556 | 174,672 | 52,111 | |
Mar 12 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 31.15 | 10,000 | 311,471 | 112,948 | 122.9 K to 112.9 K (-8.13 %) |
Mar 12 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 31.16 | 14,556 | 453,565 | 122,948 | 137.5 K to 122.9 K (-10.59 %) |
Mar 12 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.00 | 14,556 | 174,672 | 137,504 | 122.9 K to 137.5 K (+11.84 %) |
Mar 12 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 31.16 | 35,444 | 1,104,435 | 122,948 | 158.4 K to 122.9 K (-22.38 %) |
Mar 12 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.16 | 35,444 | 430,999 | 158,392 | 122.9 K to 158.4 K (+28.83 %) |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.16 | 12,567 | 152,815 | 41,777 | |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.16 | 37,433 | 455,185 | 54,344 | |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 12.00 | 50,000 | 600,000 | 66,667 | |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 30.42 | 50,000 | 1,520,955 | 122,948 | 172.9 K to 122.9 K (-28.91 %) |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.00 | 50,000 | 600,000 | 172,948 | 122.9 K to 172.9 K (+40.67 %) |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 28.95 | 12,567 | 363,815 | 122,948 | 135.5 K to 122.9 K (-9.27 %) |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.16 | 12,567 | 152,815 | 135,515 | 122.9 K to 135.5 K (+10.22 %) |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 28.95 | 37,433 | 1,083,685 | 122,948 | 160.4 K to 122.9 K (-23.34 %) |
Mar 06 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 12.16 | 37,433 | 455,185 | 160,381 | 122.9 K to 160.4 K (+30.45 %) |
Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 11.09 | 50,983 | 565,401 | 0 | |
Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 11.09 | 9,017 | 99,999 | 0 | |
Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 24.95 | 50,983 | 1,272,026 | 122,846 | 173.8 K to 122.8 K (-29.33 %) |
Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 11.09 | 50,983 | 565,401 | 173,829 | 122.8 K to 173.8 K (+41.50 %) |
Jan 04 2013 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 11.09 | 9,017 | 99,999 | 122,846 | 113.8 K to 122.8 K (+7.92 %) |
Dec 19 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 11.09 | 50,000 | 554,500 | 50,983 | |
Dec 19 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.29 | 4,554 | 46,861 | 0 | |
Dec 19 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.20 | 7,864 | 80,213 | 0 | |
Dec 19 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 23.70 | 50,000 | 1,184,955 | 113,829 | 163.8 K to 113.8 K (-30.52 %) |
Dec 19 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 11.09 | 50,000 | 554,500 | 163,829 | 113.8 K to 163.8 K (+43.93 %) |
Dec 19 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.29 | 4,554 | 46,861 | 113,829 | 109.3 K to 113.8 K (+4.17 %) |
Dec 19 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.20 | 7,864 | 80,213 | 109,275 | 101.4 K to 109.3 K (+7.75 %) |
Nov 15 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.29 | 24,811 | 255,305 | 0 | |
Nov 15 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 23.59 | 24,811 | 585,354 | 101,411 | 126.2 K to 101.4 K (-19.66 %) |
Nov 15 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.29 | 24,811 | 255,305 | 126,222 | 101.4 K to 126.2 K (+24.47 %) |
Nov 15 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 23.60 | 2,516 | 59,370 | 101,411 | 103.9 K to 101.4 K (-2.42 %) |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.33 | 6,771 | 69,944 | 0 | |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 6.74 | 4,539 | 30,593 | 0 | |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 5.63 | 14,219 | 80,053 | 0 | |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 5.07 | 3,649 | 18,500 | 0 | |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 4.45 | 5,397 | 24,017 | 0 | |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 4.45 | 5,397 | 24,017 | 103,927 | 98.5 K to 103.9 K (+5.48 %) |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 5.63 | 14,219 | 80,053 | 98,530 | 84.3 K to 98.5 K (+16.86 %) |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 5.07 | 3,649 | 18,500 | 84,311 | 80.7 K to 84.3 K (+4.52 %) |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 6.74 | 4,539 | 30,593 | 80,662 | 76.1 K to 80.7 K (+5.96 %) |
Nov 09 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.33 | 6,771 | 69,944 | 76,123 | 69.4 K to 76.1 K (+9.76 %) |
Oct 16 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.29 | 25,000 | 257,250 | 24,811 | |
Oct 16 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 25.01 | 25,000 | 625,295 | 69,352 | 94.4 K to 69.4 K (-26.50 %) |
Oct 16 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.29 | 25,000 | 257,250 | 94,352 | 69.4 K to 94.4 K (+36.05 %) |
Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 26.10 | 61,169 | 1,596,511 | 61,169 | |
Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | A | 26.10 | 3,831 | 99,989 | 3,831 | |
Aug 22 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Grant | A | 0.00 | 26,000 | 0 | 69,352 | 43.4 K to 69.4 K (+59.97 %) |
Aug 15 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 24.01 | 25,000 | 600,290 | 43,352 | 68.4 K to 43.4 K (-36.58 %) |
Jun 20 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Option Exercise | M | 10.29 | 25,000 | 257,250 | 49,811 | |
Jun 20 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Sell | S | 25.36 | 25,000 | 634,000 | 68,073 | 93.1 K to 68.1 K (-26.86 %) |
Jun 20 2012 | SGEN | SEATTLE GENETICS I ... | DOBMEIER ERIC | Chief Operating Off ... | Buy | M | 10.29 | 25,000 | 257,250 | 93,073 | 68.1 K to 93.1 K (+36.73 %) |